An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Chronic systemic complex I inhibition caused by rotenone exposure induces features of Parkinson's disease (PD) in rats, including selective nigrostriatal dopaminergic degeneration and formation of ubiquitin- and alpha-synuclein-positive inclusions (Betarbet et al., 2000). To determine underlying mechanisms of rotenone-induced cell death, we developed a chronic in vitro model based on treating human neuroblastoma cells with 5 nm rotenone for 1-4 weeks. For up to 4 weeks, cells grown in the presence of rotenone had normal morphology and growth kinetics, but at this time point, approximately 5% of cells began to undergo apoptosis. Short-term rotenone treatment (1 week) elevated soluble alpha-synuclein protein levels without changing message levels, suggesting that alpha-synuclein degradation was retarded. Chronic rotenone exposure (4 weeks) increased levels of SDS-insoluble alpha-synuclein and ubiquitin. After a latency of >2 weeks, rotenone-treated cells showed evidence of oxidative stress, including loss of glutathione and increased oxidative DNA and protein damage. Chronic rotenone treatment (4 weeks) caused a slight elevation in basal apoptosis and markedly sensitized cells to further oxidative challenge. In response to H2O2, there was cytochrome c release from mitochondria, caspase-3 activation, and apoptosis, all of which occurred earlier and to a much greater extent in rotenone-treated cells; caspase inhibition provided substantial protection. These studies indicate that chronic low-grade complex I inhibition caused by rotenone exposure induces accumulation and aggregation of alpha-synuclein and ubiquitin, progressive oxidative damage, and caspase-dependent death, mechanisms that may be central to PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“…-synuclein; cytochrome c; glutathione; caspase-3; carbonyls; ubiquitin Parkinson’s disease (PD) is marked by selective nigrostriatal dopaminergic degeneration and formation of ubiquitin- and -synuclein-positive cytoplasmic inclusions known as Lewy bodies (Spillantini et al., 1997; Wooten, 1997).”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Self-citationMITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
Turrens, J. F., & Boveris, A. (1980) · Biochemical Journal · doi:10.1042/bj1910421 · Cited by 1,601
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & -Y. Lee, V. M. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,546
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Trounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 739
Hartmann, A., Hunot, S., Michel, P. P., Muriel, M.-P., Vyas, S., Faucheux, B. A., Mouatt-Prigent, A., Turmel, H., Srinivasan, A., Ruberg, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556597 · Cited by 715
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714
The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., & Richardson, R. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1346 · Cited by 639
ΔΨ m ‐Dependent and ‐independent production of reactive oxygen species by rat brain mitochondria
Votyakova, T. V., & Reynolds, I. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00548.x · Cited by 601 · cited 2×
“Furthermore, rotenone itself induces oxidative damage (Votyakova and Reynolds, 2001; Zhang et al., 2001).”
BackgroundDityrosine Cross-linking Promotes Formation of Stable α-Synuclein Polymers
Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M.-Y., & Ischiropoulos, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000206200 · Cited by 563
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Failure of the ubiquitin-proteasome system in Parkinson’s disease
McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086067 · Cited by 519
Physiology and Anatomy of Possible Oscillators in the Central Nervous System
Rothwell, J. C. (2008) · Movement Disorders · doi:10.1002/mds.870131304 · Cited by 511
Floor, E., & Wetzel, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010268.x · Cited by 452
Lee, H.-J., Choi, C., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107045200 · Cited by 450
Degradation of α-Synuclein by Proteasome
Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417 · cited 2×
“gested that impairment of UPS function may be central to PD pathogenesis (Bennett et al., 1999; McNaught et al., 2001; Rideout et al., 2001).”
BackgroundTatton, N. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7489 · Cited by 411
Vila, M., Vukosavic, S., Jackson‐Lewis, V., Neystat, M., Jakowec, M., & Przedborski, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740721.x · Cited by 388
Titrating the Effects of Mitochondrial Complex I Impairment in the Cell Physiology
Barrientos, A., & Moraes, C. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16188 · Cited by 383
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
Pearce, R. K. B., Owen, A., Daniel, S., Jenner, P., & Marsden, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350
Uversky, V. N., Li, J., & Fink, A. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02597-2 · Cited by 350
Hasegawa, E., Takeshige, K., Oishi, T., Murai, Y., & Minakami, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90498-c · Cited by 319
Dumont, A., Hehner, S. P., Hofmann, T. G., Ueffing, M., Dröge, W., & Schmitz, M. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202325 · Cited by 316
Parkinson's disease, pesticides, and glutathione transferase polymorphisms
Menegon, A., Board, P. G., Blackburn, A. C., Mellick, G. D., & Couteur, D. G. L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03453-9 · Cited by 314
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Lotharius, J., & O'Malley, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005385200 · Cited by 306
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
Kowall, N. W., Hantraye, P., Brouillet, E., Beal, M. F., McKee, A. C., & Ferrante, R. J. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00041 · Cited by 291
Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
Lee, H.-J., Shin, S. Y., Choi, C., Lee, Y. H., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105326200 · Cited by 291
Inhibition of Mitochondrial ATP Generation by Nitric Oxide Switches Apoptosis to Necrosis
Leist, M., Single, B., Naumann, H., Fava, E., Simon, B., Kühnle, S., & Nicotera, P. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4514 · Cited by 275
Rideout, H. J., Larsen, K. E., Sulzer, D., & Stefanis, L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00474.x · Cited by 274
Cassarino, D. S., Fall, C. P., Swerdlow, R. H., Smith, T. S., Halvorsen, E. M., Miller, S. W., Parks, J. P., Parker, W. D., & Bennett, J. P. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00070-7 · Cited by 265
Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease
Hashimoto, M., Takeda, A., Hsu, L. J., Takenouchi, T., & Masliah, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28849 · Cited by 236
Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III
Bailey, S. M., Pietsch, E. C., & Cunningham, C. C. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00138-0 · Cited by 221
A fluorescent double‐labeling method to detect and confirm apoptotic nuclei in parkinson's disease
Tatton, N. A., Maclean‐Fraser, A., Tatton, W. G., Perl, D. P., & Warren, C. O. (1998) · Annals of Neurology · doi:10.1002/ana.410440721 · Cited by 202
King, T. D., Bijur, G. N., & Jope, R. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03005-0 · Cited by 177
(2000) · doi:10.1016/s0306-4522(00)00077-4 · Cited by 167
Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra
Ma, S. Y., Ciliax, B. J., Stebbins, G., Jaffar, S., Joyce, J. N., Cochran, E. J., Kordower, J. H., Mash, D. C., Levey, A. I., & Mufson, E. J. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990621)409:1<25::aid-cne3>3.0.co;2-e · Cited by 145
Phenotypic expression of the DYT1 mutation: A family with writer's cramp of juvenile onset
Gasser, T., Windgassen, K., Bereznai, B., Kabus, C., & Ludolph, A. C. (1998) · Annals of Neurology · doi:10.1002/ana.410440119 · Cited by 133
Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins
Seaton, T. A., Cooper, J. A. D., & Schapira, A. H. V. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00790-2 · Cited by 113
Nakamura, K., Bindokas, V. P., Marks, J. D., Wright, D. A., Frim, D. M., Miller, R. J., & Kang, U. J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.271 · Cited by 105
Programmed cell death: Does it play a role in parkinson's disease?
Burke, R. E., & Kholodilov, N. G. (1998) · Annals of Neurology · doi:10.1002/ana.410440719 · Cited by 103
Cell death and apoptosis regulating proteins in Parkinson's disease - a cautionary note
Wüllner, U., Kornhuber, J., Weller, M., Schulz, J. B., Löschmann, P.-A., Riederer, P. F., & Klockgether, T. (1999) · Acta Neuropathologica · doi:10.1007/s004010051005 · Cited by 102
Sensitization of Neuronal Cells to Oxidative Stress with Mutated Human α‐Synuclein
Ko, L., Mehta, N. D., Farrer, M. J., Easson, C., Hussey, J., Yen, S. H., Hardy, J., & Yen, S.-H. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752546.x · Cited by 92
Zhang, G., Tirmenstein, M. A., Nicholls-Grzemski, F. A., & Fariss, M. W. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2486 · Cited by 86
Chinopoulos, C., & Ádám‐Vizi, V. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00060.x · Cited by 82
Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells
Sherer, T., Trimmer, P. A., Borland, K., Parks, J. K., Bennett, J. P., & Tuttle, J. B. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03203-0 · Cited by 76
Self-citationProtein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation
Zhuang, S., Demirs, J. T., & Kochevar, I. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204867 · Cited by 55
Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells
Seyfried, J., Soldner, F., Kunz, W. S., Schulz, J. B., Klockgether, T., Kovar, K. A., & Wüllner, U. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00156-4 · Cited by 49
Sources of Reactive Oxygen Species Production in Excitotoxin-Stimulated Cerebellar Granule Cells
Болдырев, А. А., Carpenter, D. O., Huentelman, M. J., Peters, C. M., & Johnson, P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0325 · Cited by 46
Jiang, D., Jha, N., Boonplueang, R., & Andersen, J. K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00151.x · Cited by 41
Stephans, S. E., Miller, G. W., Levey, A. I., & Greenamyre, J. T. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00060-8 · Cited by 30
Self-citationBailey, S. (1999) · Medical Entomology and Zoology · Cited by 29
Mitochondrial Inhibitors Evoke Catecholamine Release from Pheochromocytoma Cells
Taylor, S. C., Shaw, S. M., & Peers, C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2894 · Cited by 25
Substrate specific effects of calcium on metabolism of rat heart mitochondria
Panov, A. V., & Scaduto, R. C. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.4.h1398 · Cited by 23
Self-citation
Cited by
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., & Robinson, J. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210432200 · Cited by 1,433
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Metadata
- Authors
- Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 7006-7015
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1930159471
- Cited by
- 581
- References
- 59
- FWCI
- 25.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.